Skip to content
Screener

Oruka Therapeutics, Inc. ORKA Unrealized Gains on Investments

Unrealized Gains on Investments at other companies

Amgen logo
AmgenAMGN
$0
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
$1K-98.9%
MoonLake Immunotherapeutics logo
MoonLake ImmunotherapeuticsMLTX
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN

Other financials

Income statement

See full
Revenue-
Operating income-$36.4M-45.2%
Net income-$31.8M-51.5%
EPS (diluted)-$0.46+93.4%

Balance sheet

See full
Cash & equivalents$49.5M-40.7%
Total debt$1.8M+90.8%
Total equity$486.7M+33.4%
Total assets$504.5M+33.8%

Cash flow

See full
Operating cash flow-$23.6M-13.0%
CapEx$73.0K+462%
Free cash flow-$23.7M-13.3%

Valuation

See full
Market cap$5.96B+1,198%
Enterprise value$5.91B+1,379%

Returns & leverage

See full
Return on equity-27.3%-11.1pp
Debt / equity0.0×
Current ratio23.8×-6.3×

Where this comes from

Reported directly by Oruka Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax.

The source filing: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026.

Filed
May 13, 2026, 4:01 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001213900-26-055769
Line itemAmortized CostGross Unrealized GainsGross Unrealized LossesFair Value
Corporate debt securities100,1363(163)99,976
Total marketable securities, current339,47871(240)339,309
Marketable securities, long-term
U.S. treasury securities75,5302(200)75,332
Corporate debt securities18,994(67)18,927
U.S. government agency securities12,905(41)12,864
Total marketable securities, long-term107,4292(308)107,123
Total cash equivalents and marketable securities$492,326$73$(553)$491,846

Item 1. Financial Statements (Unaudited)

FAQ

What is Oruka Therapeutics, Inc.'s unrealized gains on investments?
Oruka Therapeutics, Inc. (ORKA) reported unrealized gains on investments of $73K in Q1 2026.
How has Oruka Therapeutics, Inc.'s unrealized gains on investments changed year-over-year?
Oruka Therapeutics, Inc.'s unrealized gains on investments increased by 82.5% year-over-year, from $40K to $73K.
What does unrealized gains on investments mean?
This reflects the cumulative increase in the fair market value of investment securities held by the company that have not yet been sold. It serves as an indicator of the performance of the company's treasury or investment portfolio relative to initial acquisition costs.

Ask your AI about Oruka Therapeutics, Inc.'s unrealized gains on investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude